Elevida

Deprexis, an app used to help mental health, is the 11th app to be approved for medical prescription and reimbursement in Germany so far via DiGA, and MobiHealthNews learns more about the process from Julia Hagen, Health Innovation Hub.

A study recently published in the BMJ’s Journal of Neurology, Neurosurgery, and Psychiatry found that a digital interactive therapy tool designed for multiple sclerosis patients, Gaia’s Elevida, was effective in reducing MS-related fatigue.